Founded with a mission to bridge the gap between chemistry, biotechnology, and materials science, iFyber is a contract research and development organization that provides specialized testing and development services. Their core focus lies in the medical device, pharmaceutical, and consumer product industries. iFyber's offerings include biocompatibility testing, antimicrobial efficacy, novel coating development, and applications involving small molecules, peptides, and proteins. The company aims to help clients efficiently advance their innovations and tap into new markets.
Notable figures associated with iFyber include seasoned experts in preclinical research and regulatory consulting. The organization has achieved significant milestones in developing custom methods and solving complex problems for its clients. iFyber's impact is underscored by its ability to enhance the sensitivity and specificity of testing where other approaches have failed, thereby driving forward advancements in multiple high-stakes industries.
